Detalles de la búsqueda
1.
Prasugrel for Japanese Patients With Ischemic Heart Disease in Long-Term Clinical Practice (PRASFIT-Practice II)ã- Final 2-Year Follow-up Results of a Postmarketing Observational Study.
Circ J
; 84(11): 1981-1989, 2020 10 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-33012746
2.
Prasugrel for Japanese Patients With Ischemic Heart Disease in Long-Term Clinical Practice (PRASFIT-Practice II)ã- 1-Year Follow-up Results of a Postmarketing Observational Study.
Circ J
; 84(1): 101-108, 2019 12 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-31748446
3.
Prasugrel for Japanese Patients With Ischemic Heart Disease in Long-Term Clinical Practice (PRASFIT-Practice II)ã- A 3-Month Interim Analysis of a Postmarketing Observational Study.
Circ J
; 83(3): 637-646, 2019 02 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-30674776
4.
[Protection of human subjects in medical research: from the viewpoint of historical development of ethical regulations].
Nihon Ishigaku Zasshi
; 57(1): 63-70, 2011 Mar.
Artículo
en Japonés
| MEDLINE | ID: mdl-21797058
5.
Bleeding risks associated with anticoagulant therapies after percutaneous coronary intervention in Japanese patients with ischemic heart disease complicated by atrial fibrillation: A comparative study.
J Cardiol
; 77(2): 186-194, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32943280
6.
[Medical ethics in Japan].
Nihon Geka Gakkai Zasshi
; 110(2): 90-3, 2009 Mar.
Artículo
en Japonés
| MEDLINE | ID: mdl-19348201
7.
IgA-associated glomerulonephritis with membranoproliferative glomerulonephritis-like pattern in two children.
Clin Exp Nephrol
; 7(4): 284-9, 2003 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-14712358
Resultados
1 -
7
de 7
1
Próxima >
>>